Silverarc Capital Management, LLC Benitec Biopharma Inc. Transaction History

Silverarc Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$0.74 - $2.29 $364,731 - $1.13 Million	-492,880 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.96 - $2.96 $185,453 - $280,072	-94,619 Reduced 16.11%	492,880 $57,000
Q4 2021 Feb 14, 2022	BUY	$2.62 - $3.77 $234,463 - $337,377	89,490 Added 17.97%	587,499 $1.54 Million
Q3 2021 Nov 15, 2021	BUY	$3.49 - $4.26 $107,327 - $131,007	30,753 Added 6.58%	498,009 $1.78 Million
Q2 2021 Aug 16, 2021	BUY	$3.94 - $5.81 $1.84 Million - $2.71 Million	467,256 New	467,256 $1.99 Million

1.42M

Ticker BNTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,809,500
Market Cap $280M
Description
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.